Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Novel truncated indolicidin analogues display broad-spectrum antimicrobial activity

Dec. 14, 1999

Janssen patents broad-spectrum azole antifungals with improved characteristics

Dec. 14, 1999

Versicor achieves milestone in antibacterial collaboration with Novartis

Dec. 13, 1999

"Inactive" pharmaceutical excipient demonstrates potent anti-HSV activity in vitro and in vivo

Dec. 13, 1999

P&U initiates European registration process for oxazolidinone

Dec. 10, 1999

Abbott signs licensing agreement with Wakunaga for two quinolone antibiotics

Dec. 10, 1999

PS-15 as monotherapy comparable to trimethoprim/sulfamethoxazole in mice with PCP

Dec. 9, 1999

Highlights from ASTMH meeting: iron chelator with potential in drug-resistant malaria

Dec. 9, 1999

Abbott acquires U.S. marketing rights to cefdinir

Dec. 9, 1999

Antifungal collaboration extended by Genome Therapeutics and Schering-Plough

Dec. 9, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...